Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1976 Jul 1;54(13):607-12.
doi: 10.1007/BF01469025.

Control of mineralocorticoid substitution in Addison's disease by plasma renin measurement

Control of mineralocorticoid substitution in Addison's disease by plasma renin measurement

W Oelkers et al. Klin Wochenschr. .

Abstract

In 7 out-patients with Addison's disease, plasma renin activity (PRA), plasma concentrations of angiotensin II (AT II), renin substrate (PRS), potassium, sodium and total protein, hematocrit, blood pressure, heart rate and body weight were studied after 2 weeks each on 2 mg of dexamethasone, 25 mg hydrocortisone (HC), 25 mg HC + 0.05 mg 9-alpha-fluorohydrocortisone (FC), 25 mg HC + 0.1 mg FC and 25 mg HC + 0.2 MG FC. Four further patients were less extensively studied. Mean PRA (upper normal limit, ambulatory: 12 ng AT I-ml-1-h-1) after the 5 steps of incremental substitution, starting with dexamethasone, was 192, 59, 38, 24 and 9 ng AT I-ml-1-h-1 rsp. PRS did not change with increasing substitution. PRA and AT II were significantly correlated (r = 0.91; p less than 0.0001) and proved to be the most sensitive parameters of insufficient mineralocorticoid substitution. With decreasing significance, PRA also correlated with plasma protein concentration, plasma sodium concentration (negative), delta body weight (negative), heart rate, delta mean blood pressure (negative) and plasma potassium concentration. PRA or AT II measurements are useful clinical tools to control mineralocorticoid substitution in Addisonian patients. Inappropriately high substitution can be prevented by keeping PRA in the upper normal range.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Am J Physiol. 1950 Jan;160(1):89-102 - PubMed
    1. J Clin Endocrinol Metab. 1969 Apr;29(4):558-62 - PubMed
    1. Experientia. 1972 May 15;28(5):622-4 - PubMed
    1. Am J Physiol. 1959 Feb;196(2):283-6 - PubMed
    1. J Clin Endocrinol Metab. 1974 Nov;39(5):882-90 - PubMed

MeSH terms

LinkOut - more resources